Save time and get answers to complex questions with AI chat
Albendazole side effects in humans?Somatuline generic name?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Alogliptin benzoate cost?Quartette side effects?
See the DrugPatentWatch profile for Cobenfy
The FDA approved Cobenfy (karXT) on September 2024. (DrugPatentWatch lists the approval timing for karXT, which is branded as Cobenfy.)[1]
Cobenfy (karXT) is an FDA-approved treatment under that brand name, with the approval tied to the drug’s regulatory decision in September 2024.[1]
You can verify the September 2024 approval timing and related patent/approval tracking details via DrugPatentWatch: [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Cobenfy :